Sleep Neurology

Updated:   10/23/2017
Contains:  19 items

Creator: Neurology Today
Duration: 3:34
Journal: Neurology Today July 4, 2013, Volume 13, Issue 13;

At this year’s AAN annual meeting, investigators reported that among the neurodegenerative disorders associated with REM sleep behavior disorder (RBD), 94 percent were synucleinopathies, indicating, experts say, that REM sleep behavior disorder is a highly significant prognostic indicator of future neurodegenerative disease. The findings “argue that part of the selective vulnerability involved with Lewy body disease and with MSA likely involves REM sleep circuitry,” study leader Bradley Boeve, MD, chair of behavioral neurology at the Mayo Clinic in Rochester, MN, told attendees of the plenary at the AAN annual meeting. In a video interview, Neurology Today

Editor-in-chief Steven P. Ringel, MD, and Associate Editor Robert G. Holloway, MD, discuss the implications of the study and what to tell patients and their families once REM sleep behavior disorder is diagnosed.

Creator: Neurology Today
Duration: 1:43
Journal: Neurology Today
From the AAN annual meeting: What is the relationship between obstructive sleep apnea and risk for dementia? David Gill, MD, a cognitive behavioral neurologist at Unit Rehabilitation & Neurology in Rochester, NY, who chose this paper as “noteworthy” from the dementia papers at the AAN annual meeting, offers an analysis of the new data here and what it means for clinicians.